Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Synovive is a dietary supplement marketed for the support of joint health and flexibility. It is formulated with a blend of natural ingredients traditionally used to address joint discomfort and inflammation. The product typically contains a combination of glucosamine, chondroitin, and methylsulfonylmethane (MSM), which are structural components of cartilage, alongside botanical extracts such as turmeric (curcumin) and Boswellia serrata, known for their anti-inflammatory properties. Other ingredients often included are quercetin, bromelain, and methionine. Synovive is intended to promote synovial fluid health and maintain the integrity of connective tissues in individuals experiencing age-related or activity-induced joint wear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Synovive.